333 related articles for article (PubMed ID: 34491807)
21. Doxycycline versus cephalexin treatment of presumed streptococcal skin and soft tissue infection among adults presenting to the emergency department.
Taylor E; Nailor MD; Feider M; Sullivan S; Goodlet KJ
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0128223. PubMed ID: 38169286
[TBL] [Abstract][Full Text] [Related]
22. [Necrotizing soft tissue infections: role of the localization for the antibiotic management].
Wattel F; Mathieu D; Neut C; Dubreuil L; Cesari JF; Favory R
Bull Acad Natl Med; 2004; 188(3):473-86; discussion 486-90. PubMed ID: 15584657
[TBL] [Abstract][Full Text] [Related]
23. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
24. Ten years of treating necrotizing fasciitis.
Nordqvist G; Walldén A; Brorson H; Tham J
Infect Dis (Lond); 2015 May; 47(5):319-25. PubMed ID: 25715941
[TBL] [Abstract][Full Text] [Related]
25. Defining the Optimal Antibiotic Duration in Necrotizing Skin and Soft Tissue Infections: Clinical Experience from a Quaternary Referral Center.
Horn DL; Chan JD; Li K; Bulger EM; Lynch JB; Robinson BRH; Bryson-Cahn C
Surg Infect (Larchmt); 2023 Oct; 24(8):741-748. PubMed ID: 37751587
[No Abstract] [Full Text] [Related]
26. Application of Medicinal Plants as a Source for Therapeutic Agents Against Streptococcus pyogenes Infections.
Adil M; Khan R; Rupasinghe HPV
Curr Drug Metab; 2018; 19(8):695-703. PubMed ID: 29595103
[TBL] [Abstract][Full Text] [Related]
27. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
28. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
Zimbelman J; Palmer A; Todd J
Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
[TBL] [Abstract][Full Text] [Related]
29. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
30. Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model.
Marum D; Manning L; Raby E
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2137-2144. PubMed ID: 33948751
[TBL] [Abstract][Full Text] [Related]
31. [Community-acquired invasive soft tissue infections due to Streptococcus pyogenes].
Bartolomé-Álvarez J; Galán-Ros J; Ferrer-Amate F; Escribano Garaizábal E
Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):691-2. PubMed ID: 24873982
[No Abstract] [Full Text] [Related]
32. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
33. Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections.
Hidalgo-Grass C; Dan-Goor M; Maly A; Eran Y; Kwinn LA; Nizet V; Ravins M; Jaffe J; Peyser A; Moses AE; Hanski E
Lancet; 2004 Feb; 363(9410):696-703. PubMed ID: 15001327
[TBL] [Abstract][Full Text] [Related]
34. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
Sawai J; Hasegawa T; Kamimura T; Okamoto A; Ohmori D; Nosaka N; Yamada K; Torii K; Ohta M
Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
[TBL] [Abstract][Full Text] [Related]
35. Asymptomatic throat carriage rate and antimicrobial resistance pattern of Streptococcus pyogenes in Nepalese school children.
Dumre SP; Sapkota K; Adhikari N; Acharya D; Karki M; Bista S; Basanyat SR; Joshi SK
Kathmandu Univ Med J (KUMJ); 2009; 7(28):392-6. PubMed ID: 20502080
[TBL] [Abstract][Full Text] [Related]
36. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA
Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
[TBL] [Abstract][Full Text] [Related]
37. Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016.
Couture-Cossette A; Carignan A; Mercier A; Desruisseaux C; Valiquette L; Pépin J
PLoS One; 2018; 13(10):e0206289. PubMed ID: 30352091
[TBL] [Abstract][Full Text] [Related]
38. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive Therapy With Clindamycin in Streptococcal Infection.
Sprute R; Salzberger B; Götz J; Jung N; Stocker L; Fätkenheuer G
Clin Infect Dis; 2023 Jun; 76(11):2043-2044. PubMed ID: 36815297
[No Abstract] [Full Text] [Related]
40. Necrotizing Soft Tissue Infections.
Stevens DL; Bryant AE; Goldstein EJ
Infect Dis Clin North Am; 2021 Mar; 35(1):135-155. PubMed ID: 33303335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
